Group Leaders, Postdocs and PhD Students (f/m/d)

As a translational group, we develop novel neuromodulation tools and work closely together with biomedical companies to gain access to innovative neurotechnology. We combine basic studies on healthy subjects with clinical studies on patient populations, and apply the knowledge gained from these studies to refine our treatment protocols. Representative work from our group: Scherer et al. Neuroimage. 2020, Milosevic et al. Mov Disord. 2020, Naros et al. Cereb Cortex. 2020, Vukelić et al. Neuroimage. 2019, Ziegler et al. Brain Stimul. 2019, Guggenberger et al. Brain Stimul. 2018, Naros et al. Mov Disord. 2018, Khademi et al. Cereb Cortex. 2018, Kraus et al. J Neurosci. 2018.

Qualifications:

• Master’s degree or PhD in the field of Neuroscience, Cognitive Science, Biology, Computer Science, Engineering, Data Science or related fields.Solid understanding of statistical data analysis, digital signal processing and/or programming principles.
• Programming skills in Python or MATLAB and/or experience in applying statistical tools, e.g., machine learning for data analysis.
• electrophysiological techniques, e.g., BCI/BMI, tDCS/tACS, TMS, VNS, NMES, DBS, M/EEG, LFP, MER and/or EMG.

We offer:

• Access to novel brain stimulation paradigms to expand the understanding of the human brain and develop new therapies.
• Opportunity to work with in vivo electrophysiological data from patients and healthy controls.
• Support of your work with a broad range of pre-built analysis tools and assistance in designing your own approaches.
• Access to state-of-the-art technologies to generate reliable results.
• A team that is united by one vision: to enhance the understanding of the human brain in order to invent and implement new and more effective therapies.

The Institute for Neuromodulation and Neurotechnology at the University Hospital Tuebingen, Germany, unites neuroscientists, engineers, computer scientists and physicians following a common goal: To improve the lives of patients with brain disorders using state-dependent stimulation and adaptive neurotechnology for neuromodulation of the nervous system.